HUM-MOLGEN events: IBC's 14th Annual International Antibody Therapeutics

HUM-MOLGEN -> Events -> Meetings and Conferences

IBC's 14th Annual International Antibody Therapeutics

August 14, 2003

IBC Life Sciences, The Paradise Point Resort, San Diego, CA
November 30 - December 3, 2003

Learn first-hand the latest discoveries from basic research to early-stage clinical and how these advances will lead to promising therapeutics at IBC’s 14th Annual International Antibody Engineering conference. The Antibody Engineering meeting is the largest of its kind, and this year over 50 of the word’s leading experts will be presenting new information. This event will meet your highest expectations for networking and learning the latest in antibody basic science, technology and therapeutic applications. For up-to-date information on this event and to register, visit www.LifeSciencesInfo.com/antibodyeng. This event is co-located and concurrent with IBC’s Antibody Therapeutics From Clinical Development to Business Strategies. Go to www.LifeSciencesInfo.com/3020 for further details on this co-located and concurrent event with IBC’s Antibody Engineering conference.

Organized by:

IBC Life Sciences

Invited Speakers:

Keynote Address:

Douglas Lauffenburger, Ph.D., Whitaker Professor of Bioengineering, Director, Biological Engineering Division, MIT

Deadline for Abstracts:

Registration:

Phone (508) 616-5550 Fax (508) 616-5522 Email reg@ibcusa.com Online www.LifeSciencesInfo.com/antibodyeng

E-mail:

reg@ibcusa.com

Posted by:

James G. Prudhomme